NYSE:CI - CIGNA Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$205.37 -6.58 (-3.10 %)
(As of 12/14/2018 04:00 PM ET)
Previous Close$205.37
Today's Range$202.6590 - $211.5756
52-Week Range$163.02 - $227.13
Volume3.63 million shs
Average Volume1.89 million shs
Market Capitalization$51.62 billion
P/E Ratio19.63
Dividend Yield0.02%
Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers. This segment also provides Medicare Advantage and Medicare Part D plans to seniors, and Medicaid plans. The Global Supplemental Benefits segment offers supplemental health, life, and accident insurance products. The Group Disability and Life segment provides group long-term and short-term disability, group life, accident, and specialty insurance products and related services. The Other Operations segment offers corporate-owned life insurance products that are permanent insurance contracts sold to corporations to provide coverage; and run-off settlement annuity contracts. The company distributes its products and services through insurance brokers and insurance consultants; and directly to employers, unions and other groups, or individuals, as well as through direct response television and the Internet. Cigna Corporation was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Receive CI News and Ratings via Email

Sign-up to receive the latest news and ratings for CI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
Current SymbolNYSE:CI
Previous Symbol


Debt-to-Equity Ratio1.61
Current Ratio0.98
Quick Ratio0.98


Trailing P/E Ratio19.63
Forward P/E Ratio14.31
P/E Growth1.2

Sales & Book Value

Annual Sales$41.62 billion
Price / Sales1.20
Cash Flow$12.7085 per share
Price / Cash Flow16.16
Book Value$55.71 per share
Price / Book3.69


EPS (Most Recent Fiscal Year)$10.46
Net Income$2.24 billion
Net Margins6.15%
Return on Equity23.31%
Return on Assets5.01%


Outstanding Shares243,530,000
Market Cap$51.62 billion

CIGNA (NYSE:CI) Frequently Asked Questions

What is CIGNA's stock symbol?

CIGNA trades on the New York Stock Exchange (NYSE) under the ticker symbol "CI."

How often does CIGNA pay dividends? What is the dividend yield for CIGNA?

CIGNA declared a quarterly dividend on Wednesday, February 28th. Stockholders of record on Monday, March 12th will be paid a dividend of $0.04 per share on Tuesday, April 10th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.08%. The ex-dividend date is Friday, March 9th. View CIGNA's Dividend History.

How will CIGNA's stock buyback program work?

CIGNA announced that its Board of Directors has authorized a share repurchase program on Sunday, June 4th 2017, which allows the company to buyback $3,700,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase up to 9.8% of its stock through open market purchases. Stock buyback programs are typically a sign that the company's management believes its stock is undervalued.

How were CIGNA's earnings last quarter?

CIGNA Co. (NYSE:CI) released its quarterly earnings data on Thursday, November, 1st. The health services provider reported $3.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.45 by $0.39. The health services provider earned $11.45 billion during the quarter, compared to analysts' expectations of $11.19 billion. CIGNA had a return on equity of 23.31% and a net margin of 6.15%. The business's revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.83 earnings per share. View CIGNA's Earnings History.

When is CIGNA's next earnings date?

CIGNA is scheduled to release their next quarterly earnings announcement on Thursday, February 7th 2019. View Earnings Estimates for CIGNA.

How can I listen to CIGNA's earnings call?

CIGNA will be holding an earnings conference call on Friday, February 1st at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

What guidance has CIGNA issued on next quarter's earnings?

CIGNA updated its FY 2018 earnings guidance on Thursday, November, 1st. The company provided earnings per share guidance of $14.20-14.40 for the period, compared to the Thomson Reuters consensus estimate of $13.84. The company issued revenue guidance of $45.153-45.153 billion, compared to the consensus revenue estimate of $45.18 billion.

What price target have analysts set for CI?

13 analysts have issued 12 month target prices for CIGNA's shares. Their forecasts range from $194.00 to $304.00. On average, they expect CIGNA's share price to reach $239.3077 in the next twelve months. This suggests a possible upside of 16.5% from the stock's current price. View Analyst Price Targets for CIGNA.

What is the consensus analysts' recommendation for CIGNA?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CIGNA in the last year. There are currently 2 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CIGNA.

What are Wall Street analysts saying about CIGNA stock?

Here are some recent quotes from research analysts about CIGNA stock:
  • 1. According to Zacks Investment Research, "Cigna’s earnings per share of $3.84 beat the Zacks Consensus Estimate by 11.3% and increased 36% year over year. Strong performance across the company’s Global Health Care, Global Supplemental Benefits and Group Disability and Life businesses aided earnings. Shares of Cigna have outperformed its industry's growth in a year's time. The company is on track to buy Express Scripts, which should raise its rank in the health insurance industry and lead to long-term growth. The company has received approval for the merger from the Department of Justice. A robust Global Supplemental business, growing Government business, increasing membership, and strong capital position are the other positives. Strong 2018 outlook reflects business strength.  However, increase in leverage, rise in operating expenses and suspension of share buyback are concerns." (11/12/2018)
  • 2. Cantor Fitzgerald analysts commented, ". We initiate coverage of Overweight rating and a 12-month price target of $245. Cigna is a large-cap health insurance company with a focus on self-insured employers. Segment accounted for 80% of operating revenue and 77% of adjusted operating income. The company also operates supplemental benefits and group disability and life businesses. the company announced the acquisition of Express Scripts (ESRX – Not Covered), a large pharmacy benefit manager (PBM). We believe the transaction, which should close by year-end 2018, is a logical fit, both strategically and financially, with natural synergies." (9/26/2018)

Has CIGNA been receiving favorable news coverage?

Media stories about CI stock have been trending somewhat positive this week, InfoTrie reports. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. CIGNA earned a coverage optimism score of 1.2 on InfoTrie's scale. They also gave news articles about the health services provider a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the stock's share price in the next several days.

Who are some of CIGNA's key competitors?

Who are CIGNA's key executives?

CIGNA's management team includes the folowing people:
  • Mr. David Michael Cordani, Pres, CEO & Director (Age 53)
  • Mr. Eric Paul Palmer, Exec. VP & CFO (Age 41)
  • Ms. Nicole Susan Jones, Exec. VP & Gen. Counsel (Age 47)
  • Mr. Jason D. Sadler, Pres of International Markets (Age 49)
  • Ms. Mary Terese Agoglia Hoeltzel CPA, VP & Chief Accounting Officer

Who are CIGNA's major shareholders?

CIGNA's stock is owned by a number of of retail and institutional investors. Top institutional investors include Vanguard Group Inc (7.31%), BlackRock Inc. (6.93%), FMR LLC (3.68%), Dodge & Cox (3.65%), Capital World Investors (2.24%) and Massachusetts Financial Services Co. MA (2.24%). Company insiders that own CIGNA stock include Alan Muney, Christopher J Hocevar, David Cordani, Donna F Zarcone, Eric P Palmer, Hoeltzel Mary T Agoglia, Isaiah Harris, Jr, Jane E Md Henney, Jason D Sadler, John M Murabito, Lisa R Bacus, Mary T Hoeltzel, Matthew G Manders, Michael W Triplett, Nicole S Jones, Thomas A Mccarthy and William D Zollars. View Institutional Ownership Trends for CIGNA.

Which institutional investors are selling CIGNA stock?

CI stock was sold by a variety of institutional investors in the last quarter, including Dodge & Cox, Swedbank, PointState Capital LP, MERIAN GLOBAL INVESTORS UK Ltd, Levin Capital Strategies L.P., BlackRock Inc., Panagora Asset Management Inc. and Mitsubishi UFJ Trust & Banking Corp. Company insiders that have sold CIGNA company stock in the last year include Christopher J Hocevar, David Cordani, Donna F Zarcone, Hoeltzel Mary T Agoglia, Jane E Md Henney, Jason D Sadler, John M Murabito, Michael W Triplett, Nicole S Jones and William D Zollars. View Insider Buying and Selling for CIGNA.

Which institutional investors are buying CIGNA stock?

CI stock was acquired by a variety of institutional investors in the last quarter, including Capital World Investors, Capital Research Global Investors, Ruffer LLP, FMR LLC, Point72 Asset Management L.P., HealthCor Management L.P., DNB Asset Management AS and Dimensional Fund Advisors LP. View Insider Buying and Selling for CIGNA.

How do I buy shares of CIGNA?

Shares of CI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CIGNA's stock price today?

One share of CI stock can currently be purchased for approximately $205.37.

How big of a company is CIGNA?

CIGNA has a market capitalization of $51.62 billion and generates $41.62 billion in revenue each year. The health services provider earns $2.24 billion in net income (profit) each year or $10.46 on an earnings per share basis. CIGNA employs 46,000 workers across the globe.

What is CIGNA's official website?

The official website for CIGNA is http://www.cigna.com.

How can I contact CIGNA?

CIGNA's mailing address is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. The health services provider can be reached via phone at 860-226-6000 or via email at [email protected]

MarketBeat Community Rating for CIGNA (NYSE CI)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  668 (Vote Outperform)
Underperform Votes:  453 (Vote Underperform)
Total Votes:  1,121
MarketBeat's community ratings are surveys of what our community members think about CIGNA and other stocks. Vote "Outperform" if you believe CI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/15/2018 by MarketBeat.com Staff

Featured Article: Correction

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel